Cargando…

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals

Detalles Bibliográficos
Autores principales:	Kesavadev, J., Krishnan, G., Shankar, A., Basanth, A., Jothydev, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164619/ http://dx.doi.org/10.1016/j.diabres.2022.109327

Ejemplares similares

IDF21-0234 The Virtual COVID In-patient (VCIP) Care and Post Covid Symptoms: a Comparison with Conventional Care
por: Kesavadev, J., et al.
Publicado: (2022)

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

EHMTI-0236. A qualitative study of the functional impact of symptoms on migraine patients
por: Hareendran, A, et al.
Publicado: (2014)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
por: Kesavadev, Jothydev, et al.
Publicado: (2017)

P02.36. Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial
por: Barrett, B, et al.
Publicado: (2012)

Digital health and diabetes: experience from India
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection
por: Bogdanovic, J., et al.
Publicado: (2022)

IDF21-0320 Mortality and severity among Covid-19 patients who already vaccinated with inactivated Covid-19 vaccine
por: Tanod, D.V., et al.
Publicado: (2022)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A(1)chieve study
por: Kesavadev, Jothydev
Publicado: (2013)

Management Strategies for Dealing With Surges of the COVID-19 Pandemic
por: Raveendran, A.V., et al.
Publicado: (2021)

IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories
por: Dapice, A.
Publicado: (2022)

A new interventional home care model for COVID management: Virtual Covid IP
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

Time-in-range as a target in type 2 diabetes: An urgent need
por: Saboo, Banshi, et al.
Publicado: (2021)

Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

IDF21-0411 Correlation of Chest CT severity score with blood glucose levels in patients with COVID-19
por: Inamdar, A., et al.
Publicado: (2022)

Suggested use of vaccines in diabetes
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus
por: Russo, M.P., et al.
Publicado: (2022)

The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

IDF21-0370 New forms of diabetic education during the COVID-19 pandemic
por: Bukovská, A.
Publicado: (2022)

IDF21-0512 Development of Latent Autoimmune Diabetes of Adults Post SARS-COV-2 mRNA Vaccination
por: Kanzy, A., et al.
Publicado: (2022)

IDF21-0080 Determinants of acceptability to COVID-19 vaccine among the general public and diabetes population in Israel
por: Kolobov, T., et al.
Publicado: (2022)

IDF21-0690 Diabetics hospitalized for covid infection under corticosteroid therapy, what is the particularity?
por: Yousra, L., et al.
Publicado: (2022)

IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection
por: Babic, I., et al.
Publicado: (2022)

IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis
por: Forouhari, A., et al.
Publicado: (2022)

IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
por: Syukur, C., et al.
Publicado: (2022)

IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU
por: Capellan, N., et al.
Publicado: (2022)

IDF21-0496 Action Taken in the Kingdom of Bahrain for People with Diabetes (Preparedness and Response)
por: Al Hajeri, M.E.
Publicado: (2022)

IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic
por: Shahin, Y.
Publicado: (2022)

IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022)

IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait
por: Aljuailla, F., et al.
Publicado: (2022)

The Heroes of the I.D.F.
por: Gotweter, Y.
Publicado: (1967)

IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022)

IDF21-0377 Evaluation of the glycemic profile during 6 months after hospital discharge of patients with severe COVID-19
por: Lima, M., et al.
Publicado: (2022)

IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes
por: Rodriguez Montalvan, B.F., et al.
Publicado: (2022)

IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report
por: Gonzalez, L., et al.
Publicado: (2022)

Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
por: Hussein, Aliae A. R. Mohamed, et al.
Publicado: (2023)

IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection
por: Veríssimo, D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g2vl51p7c3uanjushp5o1r2e47